[Primary prevention with aspirin for cardiovascular diseases in diabetic patients. What evidence supports the criteria of the ADA?].
Maciá Bobes
Carmen
C
Ronzón Fernández
Aránzazu
A
Fernández García
Elisa
E
D000328:Adult; D000367:Age Factors; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D016001:Confidence Intervals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D011322:Primary Prevention; D012737:Sex Factors
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin